Table 3.
Comparison of unadjusted ten-year oncologic survival outcomes between men with an immediate versus delayed detectable PSA after radical prostatectomy for 3348 patients at University of California, San Francisco.
| Outcome | DELAYED Post-operative detectable PSA* | IMMEDIATE Post-operative detectable PSA* | ||||
|---|---|---|---|---|---|---|
| Lifetable estimate | Months to event | Still at risk at 10 yrs | Lifetable estimate | Months to event | Still at risk at 10 yrs | |
| % at 10 years | Median (IQR) | N | % at 10 years | Median (IQR) | N | |
| Salvage treatment | 46 | 29 (19, 46) | 82 | 81 | 12 (8, 37) | 17 |
| Metastasis-free survival | 92 | 65 (37, 92) | 174 | 79 | 15 (7, 48) | 47 |
| Prostate cancer mortality | 3 | 94 (88, 136) | 174 | 6 | 89 (69, 113) | 63 |
| All-cause mortality | 6 | 94 (60, 136) | 158 | 11 | 85 (65, 144) | 57 |
*PSA recurrence defined as 2 consecutive PSA > = 0.03 ng/ml